Intra-arterial Chemotherapy for Advanced Intraocular Retinoblastoma
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01151748
(Study abandoned; Could not obtain final SRC approval due to IND disagreements)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
up to 18 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients diagnosed with advanced intraocular retinoblastoma (International Retinoblastoma Classification group D or E*).
Patients with tumor recurrence or vitreous seeding following completion of systemic chemotherapy or previous radiation therapy.
Congenital brain anomaly identified on MRI.
History of systemic coagulopathy.
Evidence of extra ocular retinoblastoma on clinical examination or neuroimaging.